124 related articles for article (PubMed ID: 38097396)
1. Association of ITPA 94C>A genetic polymorphisms with azathioprine induced adverse effects in the South Indian population.
Deva R; Rajendran P; Ramasamy S; Selvan S; Ramasamy K
Drug Metab Pers Ther; 2024 Mar; 39(1):21-26. PubMed ID: 38097396
[TBL] [Abstract][Full Text] [Related]
2. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects.
Steponaitiene R; Kupcinskas J; Survilaite S; Varkalaite G; Jonaitis L; Kiudelis G; Denapiene G; Valantinas J; Skieceviciene J; Kupcinskas L
Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571
[TBL] [Abstract][Full Text] [Related]
3. Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients.
Xiong H; Xin HW; Wu XC; Li Q; Xiong L; Yu AR
Fundam Clin Pharmacol; 2010 Jun; 24(3):393-400. PubMed ID: 19682085
[TBL] [Abstract][Full Text] [Related]
4. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
5. Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.
von Ahsen N; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Oellerich M; Kruis W; Reinshagen M; Schütz E
Clin Chem; 2005 Dec; 51(12):2282-8. PubMed ID: 16214825
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD
Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
Gearry RB; Roberts RL; Barclay ML; Kennedy MA
Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation.
Breen DP; Marinaki AM; Arenas M; Hayes PC
Liver Transpl; 2005 Jul; 11(7):826-833. PubMed ID: 15973722
[TBL] [Abstract][Full Text] [Related]
9. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.
Zabala-Fernández W; Barreiro-de Acosta M; Echarri A; Carpio D; Lorenzo A; Castro J; Martínez-Ares D; Pereira S; Martin-Granizo I; Corton M; Carracedo A; Barros F
J Gastrointestin Liver Dis; 2011 Sep; 20(3):247-53. PubMed ID: 21961091
[TBL] [Abstract][Full Text] [Related]
10. Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment.
Uchiyama K; Nakamura M; Kubota T; Yamane T; Fujise K; Tajiri H
J Gastroenterol; 2009; 44(3):197-203. PubMed ID: 19214663
[TBL] [Abstract][Full Text] [Related]
11. Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment.
Tsuchiya A; Aomori T; Sakamoto M; Takeuchi A; Suzuki S; Jibiki A; Otsuka N; Ishioka E; Kaneko Y; Takeuchi T; Nakamura T
Pharmazie; 2017 Jan; 72(1):22-28. PubMed ID: 29441893
[TBL] [Abstract][Full Text] [Related]
12. Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease.
Shipkova M; Franz J; Abe M; Klett C; Wieland E; Andus T
Ther Drug Monit; 2011 Jun; 33(3):321-8. PubMed ID: 21544018
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
[TBL] [Abstract][Full Text] [Related]
14. Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis.
Barba E; Kontou PI; Michalopoulos I; Bagos PG; Braliou GG
Pharmacogenomics J; 2022 Feb; 22(1):39-54. PubMed ID: 35034963
[TBL] [Abstract][Full Text] [Related]
15. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
Kurzawski M; Dziewanowski K; Lener A; Drozdzik M
Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
[TBL] [Abstract][Full Text] [Related]
16. Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine.
Yamamoto K; Okada Y; Nakamura K; Hiromura K; Nojima Y; Nakamura T
Expert Opin Drug Saf; 2010 May; 9(3):447-57. PubMed ID: 20367526
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Study Evaluating Metabolic Capacity of Thiopurine and Associated Adverse Reactions in Japanese Patients with Inflammatory Bowel Disease (IBD).
Odahara S; Uchiyama K; Kubota T; Ito Z; Takami S; Kobayashi H; Saito K; Koido S; Ohkusa T
PLoS One; 2015; 10(9):e0137798. PubMed ID: 26360046
[TBL] [Abstract][Full Text] [Related]
18. Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease.
Al-Judaibi B; Schwarz UI; Huda N; Dresser GK; Gregor JC; Ponich T; Chande N; Mosli M; Kim RB
J Popul Ther Clin Pharmacol; 2016; 23(1):e26-36. PubMed ID: 26950049
[TBL] [Abstract][Full Text] [Related]
19. ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response.
Citterio-Quentin A; Moulsma M; Gustin MP; Lachaux A; Boulieu R
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):588-595. PubMed ID: 29327413
[TBL] [Abstract][Full Text] [Related]
20. Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus.
Nagamine A; Takenaka M; Aomori T; Okada Y; Hiromura K; Nojima Y; Araki T; Nakamura T; Yamamoto K
Am J Health Syst Pharm; 2012 Dec; 69(23):2072-8. PubMed ID: 23172266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
